NexusTrade Loading NexusTrade… Taking too long? Reload this page

About Vivos Therapeutics, Inc. Common Stock (VVOS)

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Ticker
VVOS
Exchange
XNAS
Sector
Healthcare
Industry
Medical Devices

Company profile updated October 11, 2026.

Stored market snapshot

As of October 9, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$0.15
Company market capitalization (USD)
$2,995,573.62

Research VVOS

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: